Results 81 to 90 of about 15,991 (171)

Use of Recombinant Activated Factor VIIa in a Six-Month-Old Child Due to Massive Hemorrhage During Elective Surgery for Choroid Plexus Carcinoma: Case Report

Acta Clinica Croatica, 2015
We present the use of recombinant activated factor VIIa (rFVIIa) in a 6-month-old infant that suffered massive bleeding and subsequent coagulation disturbances during elective surgery for choroid plexus carcinoma in the lateral ventricle.
Alenka Spindler Vesel, Vesna Novak-Jankovič, Branka Maldini, Neva Požar Lukanović, Kata Denić, Jasmina Markovič-Božič, Maja Šoštarič   +6 more
doaj  

Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase. [PDF]

J Thromb Haemost, 2023
Das K, Keshava S, Mukherjee T, Wang J, Magisetty J, Kolesnick R, Pendurthi UR, Rao LVM.   +7 more
europepmc   +1 more source

Pregnant Women with Severe Factor VII Deficiency Undergoing Cesarean Section Managed with a Short-Term Regimen of Recombinant Factor VIIa. [PDF]

Matern Fetal Med, 2023
Obore N, Jin W, Huiqin Q, Wei Q, Yan H, Hong Y.   +5 more
europepmc   +1 more source

Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review. [PDF]

Medicine (Baltimore), 2023
Huang C, Yu Y, Zhai N, Mo W, Lin F.
europepmc   +1 more source

Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report. [PDF]

Cureus, 2022
Enciso L, Aragón-Mendoza RL, León LA, Torres-Torres CG.   +3 more
europepmc   +1 more source

Management of a twin pregnancy patient with Glanzmann thrombasthenia might be caused by a novel ITGA2B gene mutation (c.2822G>A): a case report and family investigation

Platelets
Mutations in the ITGA2B or ITGB3 gene that encodes for the αIIbβ3 platelet integrin usually cause Glanzmann thrombasthenia (GT). This study aims to investigate the clinical characteristics of a pedigree exhibiting an inherited hemorrhagic disorder ...
Xiangcheng Liao, Ruikai Zhu, Zhigang Yang, Aiqiu Qin, Yucong Huang, Ping Li, Liling Liu, Zhuning Mo   +7 more
doaj   +1 more source

Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium. [PDF]

Acta Crystallogr D Struct Biol, 2021
Vadivel K, Schmidt AE, Cascio D, Padmanabhan K, Krishnaswamy S, Brandstetter H, Bajaj SP.   +6 more
europepmc   +1 more source

Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: Implications for the therapeutic hemostatic effect of FVIIa. [PDF]

J Thromb Haemost, 2022
Das K, Pendurthi UR, Manco-Johnson M, Martin EJ, Brophy DF, Rao LVM.   +5 more
europepmc   +1 more source

Fatal scenario following dental extraction in middle‐aged man with history of acquired hemophilia: Employment of surgical tracheostomy and use of FFP and cryoprecipitate to gain patent airway

Clinical Case Reports
Key Clinical Message Acquired hemophilia A can upshot in a life‐threatening hemorrhage and airway obstruction. Airway bleeding is a weighty emergency in hemophilia care, necessitating the immediate start of effective hemostatic therapy (porcine factor ...
Sunil Bhatta MD, Sukriti Pandit MBBS, Sabin Nepal MD, Pratik Chaudhary MD   +3 more
doaj   +1 more source

How the tissue factor-VIIa complex keeps two substrates in the loop. [PDF]

J Thromb Haemost, 2021
Schulman S.
europepmc   +1 more source